S. David Ellenbogen, Hologic’s chair and CEO, died unexpectedly June 21 from heart failure. A pioneer of bone densitometry, Ellenbogen cofounded Hologic and served as CEO and chair since its formation 16 years ago. In addition to corporate duties
S. David Ellenbogen, Hologic’s chair and CEO, died unexpectedly June 21 from heart failure. A pioneer of bone densitometry, Ellenbogen cofounded Hologic and served as CEO and chair since its formation 16 years ago. In addition to corporate duties at Hologic, Ellenbogen lobbied state and federal officials on behalf of small companies throughout the medical device industry. His professional efforts underscored the integrity and good will that friends and associates experienced firsthand. Jay A. Stein, executive vice president and CTO, has been appointed Hologic chair. Stein will serve as interim CEO, until the company’s board of directors fills the position permanently.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.